샘플 요청 목록

 카트 문의
시장보고서
상품코드
1791473

세계의 항콕시듐제 시장

Anticoccidial Drugs
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 162 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 항콕시듐제 시장은 2030년까지 2억 5,460만 달러에 이를 전망

2024년에 2억 310만 달러로 추정되는 항콕시듐제 세계 시장은 분석 기간인 2024-2030년 CAGR 3.8%로 성장하여 2030년에는 2억 5,460만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 합성 의약품은 CAGR 4.5%를 나타내고, 분석 기간 종료시에는 1억 4,810만 달러에 이를 것으로 예측됩니다. Ionophore 의약품 부문의 성장률은 분석 기간중 CAGR 2.9%로 추정됩니다.

미국 시장은 5,340만 달러로 추정되며, 중국은 CAGR 3.8%를 보일 것으로 예측

미국의 항콕시듐제 시장은 2024년에 5,340만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 3.8%로 2030년까지 4,110만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.6%와 3.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.1%를 보일 전망입니다.

세계의 항콕시듐제 시장 - 주요 동향과 촉진요인 정리

전 세계 항콕시듐제 수요를 촉진하는 요인은 무엇인가?

콕시듐증은 가축, 특히 가금류와 소에게 여전히 위협이 되고 있으며, 발병률, 폐사율, 생산성 저하로 인해 큰 경제적 손실을 초래하고 있습니다. 닭고기나 계란과 같은 단백질이 풍부한 식품에 대한 전 세계적인 수요 증가로 인해 효과적인 항콕시듐 약품의 필요성이 높아지고 있습니다. 대규모 양계 경영은 가축의 건강을 유지하고 발병을 예방하기 위해 예방 및 치료용 항콕시듐제에 크게 의존하고 있습니다. 또한, 기존 치료법에 내성을 보이는 새로운 Eimeria 기생충의 출현으로 인해 효능이 강화되고 내성 프로파일이 감소된 차세대 약물 개발에 점점 더 많은 관심이 집중되고 있습니다. 또한, 이오노포어와 합성 항콕시듐제를 통합하여 약제 내성을 최소화하면서 기생충의 제거를 최적화하는 병용요법으로의 전환이 진행되고 있습니다.

규제 압력은 항콕시듐제 시장을 어떻게 형성하고 있는가?

축산업에서 항생제 및 약용 사료 첨가제 사용을 규제하는 엄격한 규제는 항콕시듐제 시장의 역학에 큰 영향을 미치고 있습니다. FDA와 유럽의약품청(EMA)을 포함한 정부 및 규제기관은 항균제 내성(AMR) 위험을 줄이기 위해 항콕시듐제 사용에 대한 엄격한 가이드라인을 시행하고 있습니다. 이 때문에 특정 전통 약품은 단계적으로 사용이 중단되고, 제약 회사는 비항균성 콕시듐증에 대한 대체 솔루션을 개발해야 하는 상황에 직면해 있습니다. 그 결과, 업계에서는 백신 및 식물성 사료 첨가제 채택이 증가하고 있으며, 지속 가능한 가축 생산을 보장하는 동시에 규제 준수에 부합하는 새로운 항콕시듐 제제에 대한 수요가 증가하고 있습니다.

시장의 진화에서 기술 혁신이 차지하는 역할은 무엇인가?

항콕시듐제 시장은 약물 제형화, 전달 메커니즘, 정밀 축산이 발전함에 따라 기술적 변혁기를 맞이하고 있습니다. 약동학 및 표적 작용이 개선된 새로운 약물 분자가 개발되어 독성 위험을 줄이면서 치료 효과를 높이고 있습니다. 나노기술 또한 약물의 흡수와 서방형을 향상시켜 약효의 장기화를 실현하는 데 기여하고 있습니다. 또한, 질병 예찰에 인공지능(AI)과 빅데이터 분석을 통합함으로써 농가는 적시에 효과적인 콕시듐증 관리 전략을 실행할 수 있는 실시간 정보를 얻을 수 있습니다. 이러한 기술 혁신은 약효를 최적화할 뿐만 아니라 비용 효율적이고 환경적으로 지속 가능한 가축 사육 방식에 기여하고 있습니다.

시장 확대를 가속화하는 주요 성장 촉진요인은 무엇인가? 세계 항콕시듐제 시장의 성장은 고품질 동물성 단백질에 대한 수요 증가, 가축 생산량 증가, 상업용 가금류 농장 확장 등 여러 요인에 의해 주도되고 있습니다. 특히 신흥 경제권에서는 급속한 도시화와 식생활 선호도 변화로 인해 가축의 효과적인 질병 대책의 필요성이 더욱 커지고 있습니다. 또한, 동물용 의약품의 발전과 새로운 제제의 도입으로 치료의 전망이 넓어지고 있습니다. 백신 접종, 바이오 보안, 새로운 사료 첨가제를 포함한 종합적인 콕시듐증 관리로의 전환도 시장 성장을 가속하고 있습니다. 또한, 차세대 항콕시듐제 개발을 위한 제약사 및 연구기관과의 전략적 제휴는 향후 몇 년 동안 업계의 지속적인 확장을 촉진할 것으로 예측됩니다.

부문

약제 클래스별(합성 약제, Ionophore 약제), 약제 작용별(Coccidiostatic Action, Coccidiocidal Action), 동물 유형별(반려 동물, 가축 동물),

조사 대상 기업 예

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc.-MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.08.20

Global Anticoccidial Drugs Market to Reach US$254.6 Million by 2030

The global market for Anticoccidial Drugs estimated at US$203.1 Million in the year 2024, is expected to reach US$254.6 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Synthetic Drugs, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$148.1 Million by the end of the analysis period. Growth in the Ionophore Drugs segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$53.4 Million While China is Forecast to Grow at 3.8% CAGR

The Anticoccidial Drugs market in the U.S. is estimated at US$53.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.1 Million by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Anticoccidial Drugs Market - Key Trends & Drivers Summarized

What is Fueling the Demand for Anticoccidial Drugs Worldwide?

Coccidiosis remains a persistent threat to livestock, particularly in poultry and cattle, causing significant economic losses due to morbidity, mortality, and decreased productivity. The growing global demand for protein-rich foods, such as chicken and eggs, has heightened the need for effective anticoccidial drugs. Large-scale poultry farming operations rely heavily on prophylactic and therapeutic anticoccidials to maintain herd health and prevent outbreaks. Additionally, with emerging strains of Eimeria parasites displaying resistance to traditional treatments, there is an increasing focus on developing new-generation drugs with enhanced efficacy and reduced resistance profiles. The market is also experiencing a shift towards combination therapies that integrate ionophores and synthetic anticoccidials to optimize parasite control while minimizing drug resistance.

How is Regulatory Pressure Reshaping the Anticoccidial Market?

Stringent regulations governing the use of antibiotics and medicated feed additives in animal husbandry have significantly influenced the dynamics of the anticoccidial drugs market. Governments and regulatory agencies, including the FDA and the European Medicines Agency (EMA), are enforcing strict guidelines on the use of anticoccidials to mitigate antimicrobial resistance (AMR) risks. This has led to the phasing out of certain traditional drugs, compelling pharmaceutical companies to develop alternative, non-antibiotic coccidiosis control solutions. Consequently, the industry is witnessing an increased adoption of vaccines and phytogenic feed additives, alongside a rising demand for novel anticoccidial formulations that align with regulatory compliance while ensuring sustainable livestock production.

What Role Does Technological Innovation Play in Market Evolution?

The anticoccidial drugs market is undergoing a technological transformation with advancements in drug formulation, delivery mechanisms, and precision livestock farming. New drug molecules with improved pharmacokinetics and targeted action are being developed to enhance treatment outcomes while reducing toxicity risks. Nanotechnology is also gaining traction, enabling better drug absorption and sustained release for prolonged efficacy. Additionally, the integration of artificial intelligence (AI) and big data analytics in disease surveillance is empowering farmers with real-time insights to implement timely and effective coccidiosis management strategies. These innovations are not only optimizing drug efficacy but also contributing to cost-effective and environmentally sustainable livestock rearing practices.

What Are the Key Growth Drivers Accelerating the Market Expansion? The growth in the global anticoccidial drugs market is driven by several factors, including the rising demand for high-quality animal protein, increasing livestock production, and the expansion of commercial poultry farms. Rapid urbanization and evolving dietary preferences, particularly in emerging economies, are further amplifying the need for effective disease control measures in livestock. Additionally, advancements in veterinary pharmaceuticals and the introduction of novel drug formulations are expanding the treatment landscape. The shift towards integrated coccidiosis management, incorporating vaccination, biosecurity, and novel feed additives, is also fueling market growth. Furthermore, strategic collaborations between pharmaceutical companies and research institutions to develop next-generation anticoccidials are poised to drive sustained industry expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Anticoccidial Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drug Class (Synthetic Drugs, Ionophore Drugs); Drug Action (Coccidiostatic Action, Coccidiocidal Action); Animal Type (Companion Animals, Livestock Animals);

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc. - MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Anticoccidial Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Poultry and Livestock Disease Prevention Driving Market Growth
    • Expansion of Intensive Animal Farming Increasing the Need for Anticoccidial Agents
    • Rising Adoption of Ionophores and Non-Ionophore Anticoccidials in Feed Additives
    • Increasing Focus on Sustainable and Antibiotic-Free Coccidiosis Prevention
    • Surge in Development of Next-Generation Vaccines as Alternatives to Drugs
    • Expansion of Integrated Farm Management Practices Enhancing Drug Efficacy
    • Growing Investments in Herbal and Natural Anticoccidial Solutions
    • Increasing Demand for Combination Therapies for Enhanced Parasite Control
    • Advancements in Genomic Research for Targeted Coccidiosis Treatment
    • Rising Consumer Demand for Organic Meat Driving Shift Towards Natural Solutions
    • Expansion of Anticoccidial Drug Use in Companion Animals and Exotic Species
    • Growing Strategic Partnerships for Global Distribution of Anticoccidial Drugs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Anticoccidial Drugs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Synthetic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Synthetic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ionophore Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Ionophore Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coccidiostatic Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Coccidiostatic Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Coccidiocidal Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Coccidiocidal Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • JAPAN
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • CHINA
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • EUROPE
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • FRANCE
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • GERMANY
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제